Stay updated on VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.

Latest updates to the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check21 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated to reflect a new study involving VIC-1911 and sotorasib, with significant changes in the study's duration and assessment timelines, now focusing on a shorter 9-month period instead of the previous 42 months.SummaryDifference9%
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe webpage has been updated to reflect a new version of the study protocol for the VIC-1911 clinical trial, including specific details about the number of subjects anticipated in various cohorts and the removal of previous detailed descriptions of the study phases and inclusion criteria.SummaryDifference49%
Stay in the know with updates to VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.